Viewing Study NCT00498108


Ignite Creation Date: 2025-12-26 @ 10:57 AM
Ignite Modification Date: 2026-01-03 @ 5:54 PM
Study NCT ID: NCT00498108
Status: COMPLETED
Last Update Posted: 2014-09-25
First Post: 2007-07-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase 3 Open-label Extension Trial With Rotigotine in Idiopathic Restless Legs Syndrome Subjects
Sponsor: UCB Pharma
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Idiopathic Restless Legs Syndrome View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Rotigotine View
None Restless Legs Syndrome View